Jenburkt Pharmaceuticals Limited (BOM:524731)

India · Delayed Price · Currency is INR

1,158.65

-12.75 (-1.09%)

At close: May 26, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceutical Formulations	1.69B	1.52B	1.42B	1.37B	1.24B
Pharmaceutical Formulations Growth	11.24%	6.85%	3.82%	10.30%	13.44%
Total	1.69B	1.52B	1.42B	1.37B	1.24B
Total Growth	11.24%	6.85%	3.82%	10.30%	13.44%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	1.32B	1.22B	1.11B	1.03B
India Growth	8.80%	9.67%	7.96%	17.48%
Exports	190.48M	200.23M	252.58M	210.26M
Exports Growth	-4.87%	-20.73%	20.13%	-1.95%
Total	1.51B	1.42B	1.36B	1.24B
Total Growth	6.87%	4.03%	10.03%	13.65%

Source: S&P Global Market Intelligence.